drugset / Trial / NCT04274049
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate whether intramuscular injections of NL003 into the calf is safe and effective in the treatment of critical limb ischemia
Timeline
- Start
- 2019-08-28
- Primary completion
- 2023-12-23
- Completion
- 2023-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NL003 | Other / unclassified | 8 mg | Intramuscular |